AlgoRx Pharmaceuticals
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, AlgoRx Pharmaceuticals sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
AlgoRx Pharmaceuticals: 5 sponsored US clinical trials, none currently recruiting.
AlgoRx Pharmaceuticals sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Neuroma, with 1 trials.
Upper-quartile sponsor footprint
AlgoRx Pharmaceuticals sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
ALGRX 4975 After Total Knee Replacement
NCT00132392
Efficacy and Safety of ALGRX 3268 in Children Undergoing Minor Needle-Stick Procedures.
NCT00146185
Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children.
NCT00140088
ALGRX 4975 in the Treatment of Patients With Morton's Neuroma
NCT00130962
Study of ALGRX 3268 for Needlestick Pain in Children
NCT00132405
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
Therapeutic Areas
How the AlgoRx Pharmaceuticals archive is shaped
5 indexed studies, none listed as recruiting (0% open); 5 completed (100%).
Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Neuroma (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
AlgoRx Pharmaceuticals: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
AlgoRx Pharmaceuticals sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this AlgoRx Pharmaceuticals page
5 registered trials is a research-attention snapshot, not an endorsement of AlgoRx Pharmaceuticals or any single study.
- None of AlgoRx Pharmaceuticals's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Neuroma is the condition AlgoRx Pharmaceuticals studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Neuroma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
AlgoRx Pharmaceuticals pipeline card: 5 registered trials from official public datasets.Report a data error.